DASH prediction score: Difference between revisions

Jump to navigation Jump to search
Amandeep Singh (talk | contribs)
Amandeep Singh (talk | contribs)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}}; {{AE}} (insert your name here)
{{CMG}}; {{AE}} (insert your name here)


Line 27: Line 28:
{| class="wikitable"
{| class="wikitable"
|+
|+
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Score
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Score
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Annualized recurrence rate
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Annualized recurrence  
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Cumulative recurrence rate
rate (%)
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Cumulative recurrence rate(%)
|-
|-
! style="background:#4479BA; color: #FFFFFF;" align="center" + |1 year
! style="background:#4479BA; color: #FFFFFF;" align="center" + |1 year
Line 35: Line 37:
! style="background:#4479BA; color: #FFFFFF;" align="center" + |5 year
! style="background:#4479BA; color: #FFFFFF;" align="center" + |5 year
|-
|-
|style="background:#DCDCDC;" align="center" + | - 2
| style="background:#DCDCDC;" align="center" + | - 2
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |1.8
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |2.4
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |5.2
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |5.2
|-
| style="background:#DCDCDC;" align="center" + | - 1
| style="background:#F5F5F5;" align="center" + |1.0
| style="background:#F5F5F5;" align="center" + |1.9
| style="background:#F5F5F5;" align="center" + |1.9
| style="background:#F5F5F5;" align="center" + |5.7
|-
|-
|style="background:#DCDCDC;" align="center" + | - 1
| style="background:#DCDCDC;" align="center" + |0
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |2.4
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |4.2
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |5.4
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |9.5
|-
|-
|style="background:#DCDCDC;" align="center" + |
| style="background:#DCDCDC;" align="center" + |1
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |3.9
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |5.1
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |8.7
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |15.9
|-
|-
|style="background:#DCDCDC;" align="center" + |
| style="background:#DCDCDC;" align="center" + |2
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |6.3
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |8.4
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |12.8
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |25.3
|-
|-
|style="background:#DCDCDC;" align="center" + |
| style="background:#DCDCDC;" align="center" + |3
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |10.8
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |14.6
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |20.5
|style="background:#F5F5F5;" align="center" + |
| style="background:#F5F5F5;" align="center" + |40.9
|-
|-
|style="background:#DCDCDC;" align="center" + |
|4
|style="background:#F5F5F5;" align="center" + |
|19.9
|style="background:#F5F5F5;" align="center" + |
|21.9
|style="background:#F5F5F5;" align="center" + |
|33.6
|style="background:#F5F5F5;" align="center" + |
|61.3
|}
|}
* Score – 2: annualized recurrence rate 1.8%
* Score – 2: annualized recurrence rate 1.8%

Revision as of 20:11, 5 February 2019


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: (insert your name here)

Synonyms and keywords: (add synonyms and create redirects)

Overview

[Name of the Score] is a (± validated) risk assessment tool designed to assess the (30-day/10-year/other timeframe) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).

DASH Prediction Score

[Name of the Score] was invented by (Author) et al in (year), and has been externally validated in (other populations/subsequent studies).(add references)

[Name of the Score] is a (risk assessment tool/risk stratification scheme) designed to assess the (30-day/5-year) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).

[Name of the Score] is a (clinical prediction rule) devised to assess the severity of (acute pancreatitis/other disease) among (hospitalized patients/healthy individuals/other population) in the (outpatient/inpatient/surgical/medical/emergency room) setting.

[Name of the Score] is a (prediction model) developed to estimate the (mortality/bleeding rate/pre-test probability) of (acute pulmonary embolism/other disease) among (hospitalized patients/healthy individuals/other population).

[Name of the Score] is a (decision tool) designed to assist the decision-making pertaining to the (risk/benefit) of (antiplatelet/antithrombotic/other treatment) for (acute coronary syndrome/other conditions) among (hospitalized patients/healthy individuals/other population).

DASH Prediction Score Calculator

Shown below is the calculator for DASH prediction score (check all the boxes that apply):

DASH Prediction Score Calculator
Variable Score
Elevated D-dimer levels 2
Age ≤ 50 years 1
Sex-male 1
Women with hormone-associated VTE -2
DASH Prediction Score:
Interpretation:

Interpretation

Score Annualized recurrence

rate (%)

Cumulative recurrence rate(%)
1 year 2 year 5 year
- 2 1.8 2.4 5.2 5.2
- 1 1.0 1.9 1.9 5.7
0 2.4 4.2 5.4 9.5
1 3.9 5.1 8.7 15.9
2 6.3 8.4 12.8 25.3
3 10.8 14.6 20.5 40.9
4 19.9 21.9 33.6 61.3
  • Score – 2: annualized recurrence rate 1.8%
  • Score 2–3: intermediate-risk (1 to 5% mortality); consider treatment or hospitalization.
  • Score ≥ 4: high-risk (> 5% mortality); treatment/hospitalization is warranted.

See also

  • (Relevant score 1)
  • (Relevant score 2)
  • (Relevant score 3)

References